Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation

Pfeuffer S, Schmidt R, Ruck T, Kleinschnitz C, Lee DH, Linker R, Doerck S, Straeten V, Windhagen S, Pawlitzki M, Aufenberg C, Lang M, Eienbroeker C, Tackenberg B, Limmroth V, Wiendl H, Meuth SG (2019)
In: Journal of Neurology, 266(1)
Type of Publication: Research article (journal)

T-cell mediated secondary autoimmunity following alemtuzumab treatment: 2 cases of vitiligo

Ruck T, Pfeuffer S, Schulte-Mecklenbeck A, Gross CC, Lindner M, Metze D, Ehrchen J, Wiendl H, Meuth SG, Klotz L (2018)
In: Multiple Sclerosis, 24(2)
Type of Publication: Research article (journal)

Comparison of high-dose intravenous corticosteroids and therapeutic plasma exchange in acute relapsing multiple sclerosis

Lammerding L, Pfeuffer S, Bormann E, Sauerland C, Ruck T, Brand M, Schilling M, Kleinschnitz C, Wiendl H, Meuth SG (2018)
In: Multiple Sclerosis, 24(2)
Type of Publication: Research article (journal)

Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosis

Obermann M, Ruck T, Pfeuffer S, Baum J, Wiendl H, Meuth SG (2016)
In: Multiple Sclerosis, 22(9)
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation Pfeuffer S, Schmidt R, Ruck T, Kleinschnitz C, Lee DH, Linker R, Doerck S, Straeten V, Windhagen S, Pawlitzki M, Aufenberg C, Lang M, Eienbroeker C, Tackenberg B, Limmroth V, Wiendl H, Meuth SG (2019) In: Journal of Neurology, 266(1) Type of Publication: Research article (journal)
Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis-A Longitudinal Observational Study Riepl E, Pfeuffer S, Ruck T, Lohmann H, Wiendl H, Meuth SG, Johnen A (2018) In: Frontiers in Neurology, 8 Type of Publication: Research article (journal)
T-cell mediated secondary autoimmunity following alemtuzumab treatment: 2 cases of vitiligo Ruck T, Pfeuffer S, Schulte-Mecklenbeck A, Gross CC, Lindner M, Metze D, Ehrchen J, Wiendl H, Meuth SG, Klotz L (2018) In: Multiple Sclerosis, 24(2) Type of Publication: Research article (journal)
Alemtuzumab-induced changes in cerebrospinal fluid immune cell pattern - a prospective observational study Pfeuffer S, Ruck T, Lammerding L, Schulte-Mecklenbeck A, Gross CC, Wiendl H, Klotz L, Meuth SG (2018) In: Multiple Sclerosis, 24(2) Type of Publication: Research article (journal)
Comparison of high-dose intravenous corticosteroids and therapeutic plasma exchange in acute relapsing multiple sclerosis Lammerding L, Pfeuffer S, Bormann E, Sauerland C, Ruck T, Brand M, Schilling M, Kleinschnitz C, Wiendl H, Meuth SG (2018) In: Multiple Sclerosis, 24(2) Type of Publication: Research article (journal)
An Enigmatic Case of Acute Mercury Poisoning: Clinical, Immunological Findings and Platelet Function Kleffner I, Eichler S, Ruck T, Schungel L, Pfeuffer S, Polzer P, Dittrich R, Dziewas R, Gross CC, Gobel K, Wiendl H, Kehrel BE, Meuth SG (2017) In: Front Neurol, 8 Type of Publication: Research article (journal)
Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosis Obermann M, Ruck T, Pfeuffer S, Baum J, Wiendl H, Meuth SG (2016) In: Multiple Sclerosis, 22(9) Type of Publication: Research article (journal)
ACUTE CHOLECYSTITIS DURING TREATMENT WITH ALEMTUZUMAB IN 3 PATIENTS WITH RRMS Pfeuffer S, Beuker C, Ruck T, Lenze F, Wiendl H, Melzer N, Meuth SG (2016) In: Neurology, 87(22) Type of Publication: Research article (journal)